Phase 1b/II Trial of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies (Phase Ib) and Small Cell Lung Cancer Patients (Phase II) Who Have Progressed on Prior Platinum-based Chemotherapy
Phase of Trial: Phase I/II
Latest Information Update: 11 Nov 2017
At a glance
- Drugs Carfilzomib (Primary) ; Irinotecan (Primary)
- Indications Cancer; Non-small cell lung cancer; Small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 03 Nov 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 03 Nov 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 10 Jun 2017 Biomarkers information updated